DK2046369T3 - RECOMBINANT HOST FOR PREPARING L-ASPARAGINASE II - Google Patents

RECOMBINANT HOST FOR PREPARING L-ASPARAGINASE II Download PDF

Info

Publication number
DK2046369T3
DK2046369T3 DK07840229.4T DK07840229T DK2046369T3 DK 2046369 T3 DK2046369 T3 DK 2046369T3 DK 07840229 T DK07840229 T DK 07840229T DK 2046369 T3 DK2046369 T3 DK 2046369T3
Authority
DK
Denmark
Prior art keywords
asparaginase
recombinant
enzyme
seq
host cell
Prior art date
Application number
DK07840229.4T
Other languages
Danish (da)
English (en)
Inventor
David R Filpula
Maoliang Wang
Original Assignee
Sigma Tau Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Pharma Ltd filed Critical Sigma Tau Pharma Ltd
Application granted granted Critical
Publication of DK2046369T3 publication Critical patent/DK2046369T3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C12N9/82Asparaginase (3.5.1.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK07840229.4T 2006-06-30 2007-06-08 RECOMBINANT HOST FOR PREPARING L-ASPARAGINASE II DK2046369T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81781706P 2006-06-30 2006-06-30
PCT/US2007/070706 WO2008011234A2 (en) 2006-06-30 2007-06-08 Recombinant host for producing l-asparaginase ii

Publications (1)

Publication Number Publication Date
DK2046369T3 true DK2046369T3 (en) 2015-11-30

Family

ID=38957454

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07840229.4T DK2046369T3 (en) 2006-06-30 2007-06-08 RECOMBINANT HOST FOR PREPARING L-ASPARAGINASE II

Country Status (17)

Country Link
US (2) US7807436B2 (enExample)
EP (1) EP2046369B1 (enExample)
JP (1) JP5308333B2 (enExample)
KR (1) KR101408062B1 (enExample)
CN (1) CN101484181B (enExample)
AU (1) AU2007275535B2 (enExample)
CA (1) CA2652718A1 (enExample)
DK (1) DK2046369T3 (enExample)
ES (1) ES2553329T3 (enExample)
HU (1) HUE025738T2 (enExample)
IL (1) IL195168A (enExample)
MX (1) MX2009000284A (enExample)
NZ (1) NZ572519A (enExample)
PL (1) PL2046369T3 (enExample)
PT (1) PT2046369E (enExample)
TW (1) TWI427148B (enExample)
WO (1) WO2008011234A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR102014000585B1 (pt) 2014-01-10 2021-01-12 Coppe/Ufrj-Instituto Alberto Luiz Coimbra De Pós-Graduação l-asparaginase recombinante de zymomonas
CN105802948B (zh) 2014-12-29 2020-06-09 江苏众红生物工程创药研究院有限公司 聚乙二醇定点修饰的门冬酰胺酶及其制备方法与应用
US10480014B2 (en) * 2015-06-15 2019-11-19 Ajou University Industry-Academic Cooperation Foundation Method for producing natural rubber by using recombinant microorganism
EP3463308B2 (en) 2016-06-01 2026-01-07 Servier IP UK Limited Formulations of polyalkylene oxide-asparaginase and methods of making and using the same
KR101837636B1 (ko) * 2016-06-14 2018-03-12 전남대학교산학협력단 코리네박테리움 재조합 균주를 이용한 아스파라기나제의 분비생산 방법
CN108795832B (zh) * 2017-04-26 2021-05-14 江苏恒瑞医药股份有限公司 一种内源l-门冬酰胺酶ii基因敲除的宿主菌、其制备方法及其应用
WO2019083793A1 (en) 2017-10-27 2019-05-02 Pfenex Inc. Method for production of recombinant erwinia asparaginase
US10662433B2 (en) 2017-10-27 2020-05-26 Pfenex Inc. Method for production of recombinant E. coli asparaginase
US11364223B2 (en) 2018-12-13 2022-06-21 Huyabio International, Llc Sulcardine administration for treatment of acute atrial fibrillation
KR20230125179A (ko) 2020-12-23 2023-08-29 재즈 파마슈티칼즈 아일랜드 리미티드 전하-차폐 융합 단백질의 정제 방법
CN114854729B (zh) * 2021-02-03 2025-09-02 重庆派金生物科技有限公司 定向化学偶联门冬酰胺酶突变体及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122614A (en) 1989-04-19 1992-06-16 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
US5324844A (en) 1989-04-19 1994-06-28 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
US5919455A (en) 1993-10-27 1999-07-06 Enzon, Inc. Non-antigenic branched polymer conjugates
US5615460A (en) * 1994-06-06 1997-04-01 The Procter & Gamble Company Female component for refastenable fastening device having regions of differential extensibility
US6180095B1 (en) 1997-12-17 2001-01-30 Enzon, Inc. Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
US5965119A (en) 1997-12-30 1999-10-12 Enzon, Inc. Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
US6958212B1 (en) 1999-02-01 2005-10-25 Eidgenossische Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
US7122189B2 (en) 2002-08-13 2006-10-17 Enzon, Inc. Releasable polymeric conjugates based on aliphatic biodegradable linkers
US7087229B2 (en) 2003-05-30 2006-08-08 Enzon Pharmaceuticals, Inc. Releasable polymeric conjugates based on aliphatic biodegradable linkers
CN100502944C (zh) * 2005-09-16 2009-06-24 北京双鹭药业股份有限公司 一种天门冬酰胺酶注射液、其制备方法及应用

Also Published As

Publication number Publication date
TWI427148B (zh) 2014-02-21
KR20090033175A (ko) 2009-04-01
AU2007275535A1 (en) 2008-01-24
EP2046369B1 (en) 2015-08-12
WO2008011234A3 (en) 2008-10-16
KR101408062B1 (ko) 2014-06-20
CN101484181A (zh) 2009-07-15
MX2009000284A (es) 2009-01-26
US20100273236A1 (en) 2010-10-28
AU2007275535B2 (en) 2012-08-16
CN101484181B (zh) 2012-12-26
PT2046369E (pt) 2015-11-26
TW200817518A (en) 2008-04-16
ES2553329T3 (es) 2015-12-07
US20080063632A1 (en) 2008-03-13
EP2046369A2 (en) 2009-04-15
IL195168A0 (en) 2011-08-01
HUE025738T2 (en) 2016-04-28
PL2046369T3 (pl) 2016-01-29
EP2046369A4 (en) 2010-04-21
JP2009542219A (ja) 2009-12-03
NZ572519A (en) 2011-06-30
JP5308333B2 (ja) 2013-10-09
US7807436B2 (en) 2010-10-05
WO2008011234A2 (en) 2008-01-24
IL195168A (en) 2014-12-31
CA2652718A1 (en) 2008-01-24

Similar Documents

Publication Publication Date Title
EP2046369B1 (en) Recombinant host for producing l-asparaginase ii
EP1011717B1 (en) Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same
US11021690B2 (en) Mutant-type uricase, PEG modified mutant-type uricase, and application thereof
CN101812438B (zh) 一种精氨酸脱亚氨酶突变体及其制备与应用
JP2010500963A (ja) 安定化タンパク質
US12351850B2 (en) Methods of producing full-length antibodies using E. coli
KR20000067927A (ko) 박테리아 발현 시스템에서 포밀-메티오닌 펩타이드의 탈포밀화
EP4455288A1 (en) Enzyme, complex, recombinant vector, therapeutic agent for genetic disorder, and polynucleotide
SI9620043A (sl) Variante humane DNaze I
CZ267797A3 (cs) Na aktin rezistentní varianta lidské DNázy I mající hydrolytickou aktivitu štěpení DNA a izolovaná nukleová kyselina ji kodující a způsob léčby pacienta majícího plicní nemoc nebo chorobu obsahující podávání terapeuticky účinného množství na aktin rezistentní varianty lidské DNázy I a farmaceutický prostředek obsahující na aktin rezistentní variantu lidské DNázy I mající hydrolytickou aktivitu štěpení DNA
RU2486246C2 (ru) Стабильная рекомбинантная аденозиндеаминаза
HK40101360A (zh) 用於癌症、肥胖症、代谢紊乱和相关并发症及合并症的精氨酸耗竭剂的组合物和应用